Hospira (HSP) Income Statement

Click line-items for a historical chart and %

Net sales	1.18B
Cost of products sold	664.2M
Restructuring, impairment and (gain) on disposition of assets, net	-300K
Research and development	89.8M
Selling, general and administrative	211.3M
Total operating costs and expenses	965M
Income From Operations	218.6M
Interest expense	15.2M
Other income, net	-2.6M
Income Before Income Taxes
Income tax expense	62.2M
Equity income from affiliates, net	-1.3M
Net Income
Basic (in dollars per share)	0.84
Diluted (in dollars per share)	0.82
Basic (in shares)	172.8M
Diluted (in shares)	176.1M
Foreign currency translation adjustments, net of taxes $0.0 million
Pension liability adjustments, net of taxes $(1.0) million and $(0.7) million for the three months ended June 30, 2011 and 2010, respectively, and $(2.0) million and $(1.2) million for the six months ended June 30, 2011 and 2010, respectively
Unrealized (losses) gains on marketable equity securities, net of taxes $0.0 million	-800K
Reclassification of gains on terminated cash flow hedges, net of taxes $0.0 million and $(0.1) million for the three months ended June 30, 2011 and 2010, respectively, and $(0.1) million and $(0.2) million for the six months ended June 30, 2011 and 2010, respectively
Other comprehensive income (loss)
Net Income
Comprehensive Income (Loss)

Entities mentioned with HSP

View All Entities